Metraipolis › archive › dc_411ef3252d6c
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial — Europe PMC PMID:38167735
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/38167735
- DOI
- 10.1038/s41541-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T19:08:18.745Z
- SHA-256 of the archived text
f49e1459340ebee4f1f4086043f6a8b6fd454c8a1b94a86d242e9cfab35d040a- Stable URL of this page
https://metraipolis.com/documento/dc_411ef3252d6c
How to cite
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial — Europe PMC PMID:38167735 — Europe PMC (en), https://europepmc.org/article/MED/38167735 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_411ef3252d6c (Metraipolis archive dc_411ef3252d6c, sha256 f49e1459340ebee4f1f4086043f6a8b6fd454c8a1b94a86d242e9cfab35d040a)
BibTeX
@misc{dc411ef3252d6c,
title = {Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial — Europe PMC PMID:38167735},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/38167735},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_411ef3252d6c; sha256 f49e1459340ebee4f1f4086043f6a8b6fd454c8a1b94a86d242e9cfab35d040a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38167735. Agents can read the archived copy with the MCP tool read_document.